Included support
- +Hospital matching
- +Record review
- +Care coordination
- +Travel support
- +Interpretation support
Intravitreal Anti-VEGF Injection
In vitreous hemorrhage related to neovascularization (such as proliferative diabetic retinopathy), anti-VEGF injection can be considered to inhibit active bleeding or as an adjunct before and after resection. The decision is affected by the cause, fundus visibility, previous treatment response, drug
24-72h
Response window
Approx. $1,900
Treatment fee
Not included
- -Treatment fee
- -Travel costs
- -Optional extras
Hospital consultation window
Peking Union Medical College Hospital - Beijing - Grade 3A
Ruijin Hospital - Shanghai - Grade 3A
West China Hospital - Chengdu - Grade 3A
Our service process
Let us coordinate the treatment journey with you.
1
How Intravitreal Anti-VEGF Injection is performed
Under sterile conditions, the ocular surface and conjunctival sac are thoroughly disinfected. After topical anesthesia, anti-vascular endothelial growth factor (VEGF) drugs are injected into the vitreous cavity through the sclera. It is often completed in the outpatient clinic, and eye pressure and discomfort are observed for a short time after injection. Then, follow-up examinations are performed according to the plan to evaluate neovascular activity and bleeding control, and decide whether to add treatment. The above is general health information, not medical advice; specific details are subject to specialist assessment and hospital protocols.
What is Intravitreal Anti-VEGF Injection?
Under sterile conditions, the ocular surface and conjunctival sac are thoroughly disinfected. After topical anesthesia, anti-vascular endothelial growth factor (VEGF) drugs are injected into the vitreous cavity through the sclera. It is often completed in the outpatient clinic, and eye pressure and discomfort are observed for a short time after injection. Then, follow-up examinations are performed according to the plan to evaluate neovascular activity and bleeding control, and decide whether to add treatment. The above is general health information, not medical advice; specific details are subject to specialist assessment and hospital protocols.
How is Intravitreal Anti-VEGF Injection performed?
Step 1
How Intravitreal Anti-VEGF Injection is performed
Under sterile conditions, the ocular surface and conjunctival sac are thoroughly disinfected. After topical anesthesia, anti-vascular endothelial growth factor (VEGF) drugs are injected into the vitreous cavity through the sclera. It is often completed in the outpatient clinic, and eye pressure and discomfort are observed for a short time after injection. Then, follow-up examinations are performed according to the plan to evaluate neovascular activity and bleeding control, and decide whether to add treatment. The above is general health information, not medical advice; specific details are subject to specialist assessment and hospital protocols.
Recovery process
Step 1
Recovery and stay
If only one injection and follow-up are completed, it usually takes about 2–5 days; if a series of treatments are planned, the length of stay will vary depending on the schedule and evaluation results.
Request a free evaluation
Tell us about your Macular Disease case and we will help match you with the right hospital, specialist, and travel pathway.
Frequently asked questions
How do I get started?⌄
Submit a free evaluation request with your diagnosis and records. The team reviews your case and suggests suitable next steps.
Do I need a visa to travel to China for treatment?⌄
Many patients do. We can help explain what documents are normally needed for treatment travel planning.
Will there be a language barrier?⌄
Medical interpretation can be arranged for consultations and treatment visits.
How much does treatment cost?⌄
Costs depend on the procedure, hospital, and treatment pathway. A practical estimate is provided before travel.
What happens after I return home?⌄
We can help coordinate remote follow-up and keep communication open with your care team.